At least 423 common variants with low effect size have been identified by genome-wide association studies (GWAS) to have an effect on height in normal range. Mutations in >130 genes have been found in patients with short stature and in 16 with overgrowth (1,2). The SHOX gene appears to be the “master controller” of human height. Rare deleterious gene mutations affecting height have been described throughout the growth hormone-releasing hormone (GHRH)- GH- insulin-like growth factor-1 (IGF-I) pathway (3), involving the GHRH receptor, pituitary-specific transcription factors, GH, the GH receptor (Laron syndrome), post-GH receptor JAK/STAT signaling (STAT5B), IGF-I, and the type 1 IGF (IGF-1) receptor. More recently, studies have concentrated on investigations of target tissue defects involving the endochondral growth plate and its hormonal regulators. The schema below (4) has been developed in which various growth plate-centered genes have been linked to severe and mild forms of short stature, as well as to tall stature, depending on whether mutations are homozygous or heterozygous, and whether they are inhibitors (red) or activators (green) of protein regulation. With increased identification of genes that regulate growth, the number of cases of “idiopathic short stature” will inevitably decrease.
The Genetics of Growth and Growth Disorders: From the Hypothalamus to the Epiphysis
Other
The Genetics of Growth and Growth Disorders: From the Hypothalamus to the Epiphysis
J Clin Res Pediatr Endocrinol 2016;8(1):7-8
- 1Center For Endocrinology, Diabetes & Metabolism, Children’S Hospital Los Angeles, Keck School Of Medicine Of Usc, Los Angeles, California, United States Of America
Corresponding Author: Center For Endocrinology, Diabetes & Metabolism, Children’S Hospital Los Angeles, Keck School Of Medicine Of Usc, Los Angeles, California, United States Of America
Licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 (CC BY-NC-ND) International License.
CC BY-NC-ND — Attribution-NonCommercial-NoDerivatives 4.0 InternationalThe statements, opinions, and data contained in articles published in this journal are solely those of the individual author(s) and contributor(s) and do not necessarily reflect the views of the journal, its editors, editorial board, owner, or Galenos Publishing House.
Neither the journal nor Galenos Publishing House endorses or recommends any commercial product, process, service, institution, or organization that may be mentioned or advertised in the journal. The publication of advertisements, product information, or links to external websites does not constitute endorsement or approval by the journal or the publisher.
The journal, its editors, editorial board, owner, and Galenos Publishing House make reasonable efforts to ensure the accuracy and integrity of published content; however, they cannot be held responsible for errors, omissions, or any consequences arising from the use of information contained in the journal, to the extent permitted by applicable law.
Information published in the journal is intended for scientific and educational purposes and should not be considered a substitute for professional medical advice, diagnosis, or treatment. Readers should consult appropriately qualified healthcare professionals regarding individual medical conditions or treatment decisions.
External links are provided for informational convenience only. The journal and Galenos Publishing House are not responsible for the availability, accuracy, content, privacy practices, or policies of external websites.
